Success in Medical Technology

ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)

LEUVEN, Belgium and LUND, Sweden, January 26 /PRNewswire-FirstCall/ -- ThromboGenics NV (EURONEXT:THR) and BioInvent International AB (OMXS:BINV) announce today that they have received a technology transfer success fee of EUR5 million from Roche under the terms of their strategic alliance for ...

Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes

MONTVALE, N.J., Sept. 11 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI ) today announced findings from a study that indicated Synvista's proprietary monoclonal enzyme immunoassay can determine a person's haptoglobin pheno/genotype in less than two hours, and can aid physici...

ACORN Continues Success in Oncology Data Warehousing With Accumulation of Nearly 50 Million Data Observations

MEMPHIS, Tenn., June 16 /PRNewswire/ -- Accelerated Community Oncology Research Network(TM), an oncology-focused CRO and research network, announced today that its Oncology Data Warehouse has accumulated nearly 50 million data observations from over 110,000 oncology patients contained in its d...

TriMix Gel Achieves Success Among Men Who Have Failed to Achieve Erections With Viagra, Levitra and Cialis Type Tablets

ORLANDO, Fla., June 5 /PRNewswire/ -- New research presented at the recent American Urological Association Conference by Urologist Joel L. Marmar, M.D., showed that among men who previously failed to achieve erections on Viagra, Levitra and Cialis type tablets, 40% achieved an erection suffici...

Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting

- Speakers include industry and customer thought leaders - SAN FRANCISCO, May 16 /PRNewswire/ -- Velos, Inc., the recognized leader and trusted resource for clinical trial management systems this week hosted a constellation of prestigious academic medical centers, research institutions ...

NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection

HELSINGBORG, Sweden, April 15 /PRNewswire/ -- NOLabs AB, the Swedish medtech company focusing on developing innovative Nitric Oxide-containing medical devices, today reported that it has achieved another important milestone in the development of a new preventive therapy against urinary tract i...

Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate

Dr. Gregory Ellison, Director of Advanced Medical Center, Licensed to Administer PROMETA(R) PHOENIX, April 11 /PRNewswire/ -- With Arizona facing a critical crisis of methamphetamine use, Dr. Gregory Ellison, Director of Advanced Medical Center, has identified a very p...

Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))

LOGAN, Utah, Oct. 19 /PRNewswire/ -- Facet Solutions, Inc. announced today that John Regan, M.D., a board-certified orthopedic surgeon at Century City Doctors Hospital in Los Angeles, California; and Darryl DiRisio, M.D., associate professor and neurosurgeon at Albany Medical College, Albany, ...

Aiming at Multiple Alzheimer's Proteins May be Key to Success

CLARKSBURG, Md., Oct. 21 /PRNewswire/ -- An independent team of scientists is leading Alzheimer's disease research in a new, promising direction. Through a $1 million grant they received last year from Alzheimer's Disease Research, a program of the American Health Assistance Foundation (AHAF),...

Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success

WALTHAM, Mass. and DANVILLE, Pa., Sept. 18 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI ), and Geisinger Health System, today announced a research collaboration to explore the role of genetics in obesity. The goal of the collaboration is to develop a series of genetic tests...

Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success

Study Highlights Performance of Abbott's ARCHITECT Tacrolimus Assay, Only Automated Transplant Monitoring Test that Meets International Standards for Low-Level Monitoring WASHINGTON, July 30 /PRNewswire-FirstCall/ -- The ability of blood tests to precisely measure very ...

Study Finds Personal and Web-Based Support Equal Weight Loss Success

Kaiser Permanente Helps Members Achieve Weight Loss with Education & Outreach OAKLAND, Calif., March 11 /PRNewswire/ -- Findings in the Journal of the American Medical Association on the largest weight loss maintenance study to date reinforce Kaiser Permanente'...

Improved Cornea Surgery Technique Provides Enhanced Transplant Success

Researcher at American Academy of Ophthalmology Annual Meeting Describes Advance in Treatment of Endothelial Disease NEW ORLEANS, Nov. 12 /PRNewswire/ -- In a research presentation today at the American Academy of Ophthalmology's Annual Meeting, Massimo Busin, MD, department head ...

ProNAi Announces Preclinical Success for PNT2258 Therapeutic - Curative Events in Xenograft Mice for Difficult-to-Treat Non-Hodgkin's Lymphoma

LOS ANGELES--(BUSINESS WIRE)--Apr 17, 2007 - ProNAi Therapeutics, Inc., a biopharmaceutical company pioneering a new class of nucleic-acid drugs based on DNA interference (DNAi), today announced that its lead oncology therapeutic candidate, PNT2258, has successfully demonstrated preclinical in vivo...

Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting System's Success in Mouse Model Reported in Cancer Cell

HOUSTON, July 9, 2007 - A molecularly engineered therapy selectively embeds a gene in pancreatic cancer that shrinks or eradicates tumors, inhibits metastasis, and prolongs survival with virtually no toxicity, researchers from The University of Texas M. D. Anderson Cancer Center report in the Jul...

Weight Management is Not Enough for Cannabinoid Type 1 (CB1) Receptor Antagonists to Become a Commercial Success

Huge clinical development program of first-in-class CB1 antagonist rimonabant to show benefits beyond weight reduction and avoid image as life-style drug BARCELONA, Spain | March 08, 2007 | The Business Intelligence firm La Merie S.L. reported today that Sanofi-Aventis’ first-in-class CB1 ...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

...able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery o...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...mid $20 million range, in both cases excluding non-cash stock compensation expense. "Our strong financial performance is a direct result of the success of our technology platform and business strategy. We and our partners are advancing our large and growing pipeline of 19 drugs in development. Our p...

Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership

...ew biologic processes and new or improved therapeutics for people. With a team of 550 scientists and associates, it has an impressive track record of success in translational research, and has contributed significantly to Novartis' pipeline of therapeutic candidates. The partnership between JDRF and...

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone

...on and FDA inspections, which may result in delays and increased costs; the success of the Company's foreign joint venture and licensing agreements; the Compan...aborations with industry partners and governments and the terms, timing and success of any such collaboration; the cost of filing, prosecuting, defending and e...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

...stage of development prior to regulatory approval for numerous reasons including, without limitation, safety and efficacy findings; (ii) the timing or success of the commencement or end of clinical trials and commercial launch of partnered products may be delayed or unsuccessful due to slower than anticipate...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

...est new medications for bone metastases, treatment success has been measured by whether the bone complication...lly successful products or maintain the commercial success of our existing products. Our stock price may be ...ived market opportunity, competitive position, and success or failure of our products or product candidates. ...

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

...ts products in the market (including MuGard and the size of the overall market for mucositis products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to o...

Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window

... of cases. Beyond the immediate results that showed an overwhelming success in restoring blood flow, follow-up at 90 days in 198 patients indicate that...he spine; and initiating the first-ever stroke registry to track procedural success in the treatment of acute stroke. More information on SNIS and our members'...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

...people in the United States and more than four million people in Europe. Although there are a number of medications available for patients, treatment success for any antipsychotic agent can be unpredictable because patients often respond differently to various medications. Among patients with schizophrenia...

European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK

...e of employment, inflation, interest rates and the condition of capital markets. This list of factors is not all-inclusive. In addition, the Company's success depends on the outcome of various strategic initiatives it has undertaken, all of which are based on assumptions made by the Company concerning trends...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

...for aneurysms; pioneering interventional procedures to treat fractures in the spine; and initiating the first-ever stroke registry to track procedural success in the treatment of acute stroke. More information on SNIS and our members' treatment specialties may be found at www.snisonline.org. ...

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

... any impact on our relationships with third parties as a result of the announcement of the proposed merger; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval and commercialization of our products and pipeline products; government co...

Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.

...e potential utilization by the donor or possibly first-degree relatives in a manner similar to umbilical cord blood stem cells. Based on the continued success of MenSCs in the research setting, Cryo-Cell is actively expanding its portfolio of research collaborations with world renowned scientists committed t...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

...ooking statements, including risks associated with entering into a corporate partnership agreement and reliance on a corporate partner, the timing and success of clinical trials and the commercialization of product candidates, potential problems that may arise in the clinical testing and approval process, in...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

...ma-Aldrich operates in 38 countries and has 7,800 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer success through innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winni...

July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook, Bell's Palsy and Heart Valve Repair

..., where valve flaps don't close tightly and blood flows in the wrong direction. Both problems traditionally have been addressed -- with good success and safety -- via open heart surgery. During surgery, the chest is opened, the heart is stopped, and the valve is repaired or replaced. Recovery can t...

Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

...enberg has treated more than fifty patients with Artefill due to its proven success and effectiveness for the long lasting correction of wrinkles. Dr... longer and doesn't require repeat injections. We believe we have had great success with the product over the past few years as it's easy to administer and the...

Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced

...l potential of 'friendly' microorganisms and the mechanisms in which they promote human health." "We are very pleased with the direction and success of this program. We hope this grant will continue to increase interest and raise awareness of probiotics among young researchers in the United States,...

Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

...C, or any potential pipeline candidates, including any expressed or implied statements regarding the efficacy and safety of IDX184, the likelihood and success of any future clinical trials involving IDX184 or successful development of novel combinations of direct-acting antivirals for the treatment of hepati...

Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

...ll established that a decrease in bone density may compromise the long term success of the primary surgery and may increase the difficulty and expense of revis... consultants, our market share and our overall financial performance; the success of our quality initiatives; the outcome of the informal investigation by th...

BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza

...a drug candidate discovered by BioCryst," said Jon P. Stonehouse, President and Chief Executive Officer of BioCryst. "We congratulate Shionogi on the success of these rapidly completed studies, which have the potential to lead to the first regulatory approval for peramivir." Shionogi has stated tha...

Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC

...among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN, uncertainties related to the resea...

First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices

...y Feinberg School of Medicine; University of California - San Diego Medical Center; and the University of Missouri University Hospital. "The success of the first case of the IDE study and the associated data presentations at NOSCAR are important contributions in a growing body of evidence that demo...

Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial

...ooking statements, including risks associated with entering into a corporate partnership agreement and reliance on a corporate partner, the timing and success of clinical trials and the commercialization of product candidates, potential problems that may arise in the clinical testing and approval process and...